G. Conte

Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?

F. Ungaro, I. d’Angelo, G. Costabile, 2022, ACS applied materials & interfaces.

Antarctized” antibody: an innovative engineered antibody by the CRISPR/Cas9 system Tutor: Dott.ssa

G. Vitale, G. Pignataro, Riccardo Rizzo, 2020 .

Pulmonary Safety Profile of Esc Peptides and Esc-Peptide-Loaded Poly(lactide-co-glycolide) Nanoparticles: A Promising Therapeutic Approach for Local Treatment of Lung Infectious Diseases

F. Ungaro, A. Pini, I. d’Angelo, 2022, Pharmaceutics.

Poly(lactide- co-glycolide) Nanoparticles for Prolonged Therapeutic Efficacy of Esculentin-1a-Derived Antimicrobial Peptides against Pseudomonas aeruginosa Lung Infection: in Vitro and in Vivo Studies.

F. Ungaro, I. d’Angelo, F. Quaglia, 2019, Biomacromolecules.

Assisting PNA transport through cystic fibrosis human airway epithelia with biodegradable hybrid lipid-polymer nanoparticles

F. Ungaro, G. Castaldo, I. d’Angelo, 2020, Scientific Reports.

Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: Antibacterial Activity and Toxicity In Vitro and In Vivo

F. Ungaro, A. Pini, G. Cappello, 2022, Pharmaceutics.

State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives

A. Miro, F. Quaglia, Pouria Savadi, 2024, Pharmaceutics.

PEI-Engineered Lipid@PLGA Hybrid Nanoparticles for Multimodal Delivery of Antigens and Immune Adjuvants to the Respiratory Mucosa.

A. Miro, F. Quaglia, I. d'Angelo, 2024, Advanced healthcare materials.